Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Axway Named a Leader in Latest API Management Solutions Report: https://mms.businesswire.com/media/20210427006220/en/800734/5/Axway_logo.jpg
Axway Named a Leader in Latest API Management Solutions Report


Axway (Euronext: AXW.PA), a leading provider of API management and integration software, is proud to announce that it has been positioned as a Leader in The Forrester Wave™: API Management

DGAP-News: Abivax announces a change in its governance
DGAP-News: Abivax announces a change in its governance
DGAP-News: Abivax announces a change in its governance
GEVELOT S.A.: Weekly report of share buyback August 15, 2022
GEVELOT S.A.: Weekly report of share buyback August 15, 2022
GEVELOT S.A.: Weekly report of share buyback August 15, 2022
GEVELOT S.A.: Weekly report of share buyback August 10, 2022
GEVELOT S.A.: Weekly report of share buyback August 10, 2022
GEVELOT S.A.: Weekly report of share buyback August 10, 2022
NANOBIOTIX: Voting Rights and Shares Capital of the Company: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
NANOBIOTIX: Voting Rights and Shares Capital of the Company


Regulatory News:



Nanobiotix (Paris:NANO) (NASDAQ:NBTX):



Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website

Poxel Announces Extended Cash Runway with Debt Restructuring Agreement and Equity-linked Financing Facility: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Announces Extended Cash Runway with Debt Restructuring Agreement and Equity-linked Financing Facility


POXEL SA (Euronext: POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including

Poxel Provides Corporate Update and Reports Cash and Revenue for the Second Quarter and First Half 2022: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Provides Corporate Update and Reports Cash and Revenue for the Second Quarter and First Half 2022


POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including

DGAP-News: Abivax phase 3 program with obefazimod in ulcerative colitis progresses with US IRB approval
DGAP-News: Abivax phase 3 program with obefazimod in ulcerative colitis progresses with US IRB approval
DGAP-News: Abivax phase 3 program with obefazimod in ulcerative colitis progresses with US IRB approval
GEVELOT S.A.: Weekly report of share buyback August 3, 2022
GEVELOT S.A.: Weekly report of share buyback August 3, 2022
GEVELOT S.A.: Weekly report of share buyback August 3, 2022
Asaf Ashkenazi zum CEO von Verimatrix ernannt: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Asaf Ashkenazi zum CEO von Verimatrix ernannt


Verimatrix (Euronext Paris: VMX) (Paris:VMX) hat heute die Ernennung von Asaf Ashkenazi zum Chief Executive Officer mit Wirkung zum 1. August 2022 bekannt gegeben. Amedeo D'Angelo, seit 2015

Kaufman & Broad SA: PRESS RELEASE OF THE HALF YEARLY FINANCIAL REPORT
Kaufman & Broad SA: PRESS RELEASE OF THE HALF YEARLY FINANCIAL REPORT
Kaufman & Broad SA: PRESS RELEASE OF THE HALF YEARLY FINANCIAL REPORT
Asaf Ashkenazi Named CEO of Verimatrix: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Asaf Ashkenazi Named CEO of Verimatrix


Regulatory News:



Verimatrix (Euronext Paris: VMX) (Paris:VMX), today announced the appointment of Asaf Ashkenazi as Chief Executive Officer effective Monday, August 1st, 2022. Amedeo D’Angelo

GEVELOT S.A.: Weekly report of share buyback July 27, 2022
GEVELOT S.A.: Weekly report of share buyback July 27, 2022
GEVELOT S.A.: Weekly report of share buyback July 27, 2022
Axway Software: Accelerated Migration to Cloud Offerings: https://mms.businesswire.com/media/20210427006220/en/800734/5/Axway_logo.jpg
Axway Software: Accelerated Migration to Cloud Offerings


Regulatory News:



Axway Software's (Paris:AXW) Board of Directors, chaired by Pierre Pasquier, today approved the financial statements for the first half of 2022, which were subject to a limited

Kaufman & Broad SA: Renewal of the mandate relating to the share buyback program
Kaufman & Broad SA: Renewal of the mandate relating to the share buyback program
Kaufman & Broad SA: Renewal of the mandate relating to the share buyback program
Verimatrix und Harmonic arbeiten beim SaaS-schnellen Schutz von Streaming-Inhalten zusammen: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix und Harmonic arbeiten beim SaaS-schnellen Schutz von Streaming-Inhalten zusammen


Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass Harmonic als einer der ersten

Verimatrix and Harmonic Partner to Enable Streaming Content Protection at SaaS Speed: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix and Harmonic Partner to Enable Streaming Content Protection at SaaS Speed


Regulatory News:



Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Harmonic is one of the first

GEVELOT S.A.: Weekly report of share buyback July 20, 2022
GEVELOT S.A.: Weekly report of share buyback July 20, 2022
GEVELOT S.A.: Weekly report of share buyback July 20, 2022
Voyageurs du Monde enters the US market and raises its 2022 guidance, excluding external growth
Voyageurs du Monde enters the US market and raises its 2022 guidance, excluding external growth
Voyageurs du Monde enters the US market and raises its 2022 guidance, excluding external growth
ESI Group auf der International Airshow 2022 in Farnborough : https://mms.businesswire.com/media/20210510005423/de/877137/5/2020_11_04_MKTG_ESI_Logo_ColorTagline_rgb.jpg
ESI Group auf der International Airshow 2022 in Farnborough


Regulatory News:



ESI Group (ISIN Code: FR0004110310, Symbol: ESI) (Paris:ESI), ein weltweiter Softwarepartner der Industrie für Simulation und virtuelles Prototyping, wird auf der Farnborough

ESI Group at the Farnborough International Airshow 2022: https://mms.businesswire.com/media/20210510005423/de/877137/5/2020_11_04_MKTG_ESI_Logo_ColorTagline_rgb.jpg
ESI Group at the Farnborough International Airshow 2022


Regulatory News:



ESI Group (ISIN Code: FR0004110310, Symbol: ESI) (Paris:ESI), a global simulation and virtual prototyping software partner for the industry, will be present at the Farnborough

Half-year Report on the Nanobiotix Liquidity Contract With Gilbert Dupont: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
Half-year Report on the Nanobiotix Liquidity Contract With Gilbert Dupont


Regulatory News:



NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities

GEVELOT S.A.: Weekly report of share buyback July 13, 2022
GEVELOT S.A.: Weekly report of share buyback July 13, 2022
GEVELOT S.A.: Weekly report of share buyback July 13, 2022
Kaufman & Broad SA: RESULTS FOR THE FIRST HALF OF 2022
Kaufman & Broad SA: RESULTS FOR THE FIRST HALF OF 2022
Kaufman & Broad SA: RESULTS FOR THE FIRST HALF OF 2022
Nanobiotix: Voting Rights and Shares Capital of the Company: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
Nanobiotix: Voting Rights and Shares Capital of the Company


Regulatory News:



Nanobiotix (Paris:NANO)(NASDAQ:NBTX)



Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website: w